Osaic Holdings
CMMB

Osaic Holdings’s Chemomab Therapeutics CMMB Stock Holding History

Osaic Holdings’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250
Closed -$912 – 7422
2024
Q2 		$912 Buy
+250
New +$865 ﹤0.01% 6841
2024
Q1 		– Sell
-146
Closed -$297 – 7228
2023
Q4 		$297 Sell
146
-298
-67% -$785 ﹤0.01% 6968
2023
Q3 		$1.59K Sell
444
-237
-35% -$1.11K ﹤0.01% 6702
2023
Q2 		$3.58K Hold
681
– – ﹤0.01% 6456
2023
Q1 		$4.33K Sell
681
-913
-57% -$7.16K ﹤0.01% 6398
2022
Q4 		$21K Sell
1,594
-153
-9% -$1.32K ﹤0.01% 5524
2022
Q3 		$18K Sell
1,747
-185
-10% -$2.38K ﹤0.01% 5648
2022
Q2 		$29K Buy
1,932
+146
+8% +$2.03K ﹤0.01% 5354
2022
Q1 		$34K Buy
1,786
+688
+63% +$13.6K ﹤0.01% 5351
2021
Q4 		$31K Sell
1,098
-12,607
-92% -$447K ﹤0.01% 5475
2021
Q3 		$608K Buy
+13,705
New +$834K ﹤0.01% 2840
2020
Q4 		– Sell
-37
Closed -$3K – 6415
2020
Q3 		$3K Buy
+37
New +$2.51K ﹤0.01% 5709

Other funds holding CMMB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Osaic Holdings's CMMB Position: Q3 2024 in Review

Osaic Holdings sold out of Chemomab Therapeutics (CMMB) in Q3 2024, closing a stake of 250 shares — an estimated $912 sold.

Osaic Holdings first reported a position in CMMB in Q3 2020 and held it in 12 quarters. The position peaked at $608K in Q3 2021. 15 funds tracked by Wall St. Rank hold CMMB as of Q3 2024.

  • Osaic Holdings reported no remaining Chemomab Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Osaic Holdings sold 250 Chemomab Therapeutics shares in Q3 2024, an estimated $912.
  • Osaic Holdings first reported a position in Chemomab Therapeutics in Q3 2020 and held it in 12 quarters.
  • Osaic Holdings's Chemomab Therapeutics position peaked at $608K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2024.

Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.